How can shifting mindsets fuel the next wave of innovation in the pharmaceutical and life sciences industry? In what ways can we ensure the vast amounts of health data are utilized securely and effectively to foster groundbreaking medical advancements? And how is Oracle's new Health Data Intelligence poised to transform the industry in an unprecedented manner? You’ll learn all that and more with our guest Michael Fronstin, Vice President and Chief Commercial Officer at Oracle Life Sciences,...

What are the best ways to set up public, private, and academic clinical research partnerships? How do we get these public-private partnerships (PPP) to work most effectively? And who should be in charge of what in multistakeholder research collaborations? We will get those answers in more in this episode of Research in Action with our guests Rob King, President and CEO of FHI Clinical; and Dr. Kristen Lewis, Head of Clinical Operations at the Center for Vaccine Innovation and Access at PATH. ...

How can patients and their families become more integral in the clinical research process? How can patient-led research become more accepted in the scientific community? How are inspiring groups forging new, collaborative paths for science and medicine, and reshaping how medical research is conducted?  We will tackle those questions and much more in this episode with Amy Dockser Marcus, a Pulitzer Prize-winning journalist and author of the recently published book, “We the Scientists: How a...

How can an extensive collection of real-world data help find more diverse and better participants for clinical trials? How do we create a continuously learning ecosystem that helps bridge the gap between clinical research and clinical care? And what are the biggest challenges to patient record standardization and personalized healthcare? We will learn that and more in this episode with Dr. Lu de Souza, Vice President and Executive Medical Officer of the Learning Health Network, which is a...

Research reveals that 95% of patients do not participate in clinical trials. How do we find better ways to connect willing and qualified participants to clinical trials? How do we ensure diversity in participant populations? And how can we make access to clinical trials more patient-friendly? We will get those answers and more in this episode with Brandon Li, Co-Founder at Power. Power is a fast-growing startup building a patient-friendly way to get access to clinical trials and is working to...

What does a data hippie believe about the democratization of data? What role do technology companies, government, academia, industry, and other stakeholders play in life sciences and discovery? And how might walking clinical trials lead to improved precision medicine? We will get the answers to those questions and more in this episode with Dr. Chris Boone, the GVP of Research Services at Oracle Life Sciences. Chris has held some prominent roles at AbbVie and Pfizer, influencing health...

What is the rare Gaucher disease and how does it impact patients, families, and life sciences? Is enough emphasis being placed on research and discovery for rare diseases? And what are the patient-centered approaches that best serve those battling rare diseases? We will get those answers and more in this episode with Tanya Collin-Histed, CEO of the International Gaucher Alliance. Tanya has been a longtime driving force in supporting patients with rare diseases and advocating for world-class...

What is the rare Gaucher disease and how does it impact patients, families, and life sciences? Is enough emphasis being placed on research and discovery for rare diseases? And what are the patient-centered approaches that best serve those battling rare diseases? We will get those answers and more in this episode with Tanya Collin-Histed, CEO of the International Gaucher Alliance. Tanya has been a longtime driving force in supporting patients with rare diseases and advocating for world-class...

International Data Corporation reports safety caseloads are increasing by 30% to 50% each year, and emerging technology will be the only way to keep up. But how are powerful technologies like generative AI advancing safety and pharmacovigilance? Is touchless case processing a good or bad thing? And how do we balance AI, automation, and the human touch? We will get answers to those questions and more in this episode with Bruce Palsulich, Vice President of Safety Solutions at Oracle Life...

How is clinical research becoming more patient-focused and more convenient for patients to participate in clinical trials? Why is a decentralized approach especially important concerning rare diseases? And how will digital innovation advance the way clinical research is conducted? We will learn those answers and more in this episode with Scott Schliebner, an innovative life sciences executive with 30 years of experience across the biopharma, CRO, medtech, and non-profit sectors. With a...

How is academia fostering research that later turns into startup companies? What are new computational powers bringing to in silico drug design? And what is MoveableType methodology and why should pharma be excited about it? We will learn those answers and more in this episode with Lance Westerhoff, President and General Manager of QuantumBio. QuantumBio is a biotech startup operating in the vast field of drug discovery and molecular design. As President and GM, Lance oversees QuantumBio’s...

What are the 17 United Nations Sustainable Development Goals? What are the biggest challenges in pursuing and achieving those goals? How does technology play a role? And what’s the best way for government, academia, and industry to cooperate and collaborate in support of fundamental research? We will learn those answers and more in this episode with Declan Kirrane, the Chairman of the Science Summit at the United Nations General Assembly, and founder and managing director of ISC Intelligence...

How is computer vision being used to spot autism symptoms much earlier in children? What is augmented cognition? And how can you use AI to make data models work even with small data sets? We will learn those answers and more in this episode with Dr. Sarah Ostadabbas. Dr. Ostadabbas is an associate professor in Electrical and Computer Engineering at Northeastern University, where she is also the director of the Augmented Cognition Laboratory (ACLab), which works at the intersection of computer...

How do the latest technologies impact epidemiology, clinical research, and public health? What kind of progress has there been in collaboration, open data, and citizen science? And in what ways can digital health appropriately supplement healthcare with the human touch? We will get the answers to these questions and more in this episode with Christine Ballard, a professionally trained epidemiologist specializing in clinical research and a Research Advocate at Oracle for Research. Christine...

How do you connect the needs of researchers to the capabilities of technology? What are the main stages of research and the challenges faced at each stage? And will AI and machine learning speed up research and get solutions to market faster? We will learn those answers and more in this episode with Dr. Mark Hoffman, the Chief Research Information officer for Children’s Mercy and the Children’s Mercy Research Institute, a position he has held since 2016. Dr. Hoffman earned his doctorate in...

How can researchers who have developed innovative solutions begin to commercialize? What makes a great research-entrepreneur? And how are universities and organizations helping to bridge the research-to-commercialization gap? We will learn those answers and more in this episode with Laure Haak. A neuroscientist by training, Laure has a BS and MS in Biology and Ph.D. in Neuroscience from Stanford University, and she did postdoctoral work at the National Institutes of Health. Her career...

What is in silico drug design? And what role is it playing in drug discovery? How is cloud computing removing the limitations for in silico screening? We will learn those answers and more in this week’s episode with Dr. John Bruning, a Senior Lecturer in the School of Biological Sciences at the University of Adelaide in Southern Australia, where he also founded the University’s laboratory of protein crystallography. Dr. Bruning is also an Oracle for Research Fellow and was named a finalist...

How did we get where we are today with AI and machine learning? What are the ways Large Language Models (LLMs) can be applied to healthcare? And what about that suggested pause on advanced AI? We will explore those questions and much more in this episode with Dr. James Benoit, a postdoctoral researcher at the Women and Children's Health Research Institute (WCHRI) in Canada, where his research focuses on the use of Large Language Models (LLMs) and artificial intelligence to improve healthcare...

What is carbon capture and storage and how can it help fight climate change? Why should we be more excited about earth worms and research advocates? And how is cloud computing tying it all together for better global health? We’ll explore those issues and more in this episode with Dr. Ryan Payton, a Senior Research Advocate for Oracle, and an environmental scientist. Ryan earned his PhD at Royal Holloway, University of London, in Geological and Earth Sciences, where his research focused on the...

How can patients and their families become more integral in the research process and drug discovery? How can citizen scientists and patient-led research become more accepted in the scientific community? And who qualifies as a citizen scientist? We will tackle those questions and much more in this episode with Amy Dockser Marcus, a Pulitzer Prize-winning journalist and author of the recently published book, “We The Scientists: How a daring team of parents and doctors forged a new path for...

What are the obstacles to faster pharmaceutical and medical research? And is there such a thing as a comprehensive biomedical search and AI engine? We will learn those answers and more with guest Matteo Ghetti, cofounder of Sweden-based startup PapersHive. PapersHive is a biomedical search and AI engine to help researchers and medical professionals get to scientific research evidence faster. And this matters a lot with the emergence of evidence-based medicine making R&D in drug...

How is machine learning helping orthopedic surgeons predict better outcomes for patients? And how can those algorithms help predict how bone fracture surgery is approached? We will get those answers and much more on this episode with Dr. Akash Shah, Resident Physician in the Department of Orthopaedic Surgery at UCLA Medical Center. Dr. Shah received his Bachelor of Science at Duke University, and he went on to graduate from Harvard Medical School. He is also part of the team in the Department...

How is Open Data and Open Science being encouraged and nurtured across the global research community? What are the biggest challenges and benefits? And how are industry players like Oracle helping? We’ll be exploring those questions and much more with Hilary Hanahoe, Secretary General of the Research Data Alliance (RDA). RDA is a global community-driven organization with the goal of building the social and technical infrastructure to enable open sharing and re-use of data. As Secretary...

What is Human Activity Recognition and why is it so important for Parkinson’s research? What is the relationship between freezing of gait or FOG and brain circuitry? And how are edge computing, wearables, AI, and self-reporting helping researchers in the fight against Parkinson’s? We’ll be exploring those questions and much more with two Emory University professors focused on better understanding Parkinson’s to help push toward a cure. Dr. Lucas McKay is an Assistant Professor of Biomedical...